Sarepta Therapeutics CEO says drug launch is 'going very well' as shares rally 38% this month
0
Dr. Ed Kaye gives an update on Sarepta Therapeutics in an exclusive interview with CNBC's Meg Tirrell.
Dr. Ed Kaye gives an update on Sarepta Therapeutics in an exclusive interview with CNBC's Meg Tirrell.